The Japanese firm Astellas Pharma will apply for planning permission to construct a drug manufacturing facility in Tralee, Co. Kerry, Ireland worth around €330 million ($352 million).
Wasdell, a UK-based packaging and manufacturing provider in the UK, has opened a quality control laboratory in Dundalk to analyze products for its pharmaceutical clientele.
As part of an evaluation of its manufacturing network, the company concluded that the Ringaskiddy production building was no longer a competitive, long-term option.
As part of its global network expansion strategy, PCI Pharma Services is investing in a new dedicated clinical facility near Dublin, Ireland, which will provide space for secondary packaging, storage, logistics, and distribution.
The Wasdell Group’s new EU headquarters in Dundalk, Ireland is set to commence operations later this year as part of the company’s “proactive contingency plan” ahead of Brexit.
Basic pharmaceuticals including APIs became even more important revenue generators for Ireland in 2013 according to new data released by the Central Statistics Office (CSO).
Pfizer has welcomed Government commitments to keep Ireland’s 12.5 per cent corporation tax rate in face of recent EU pressure to increase it as a condition of the €85bn 7-year IMF bailout.
Rottapharm is investing €7m ($9.8m) in its Irish manufacturing operations, which will create 35 jobs and add 2000 sq m housing three manufacturing and associated packaging lines.
Merck has settled on a site in south east Ireland for a new
vaccines and biologics facility, investing €200m ($280m) in its
third facility on the island.
Major biopharma Gilead Sciences has announced plans to invest in a
new €60m plant in west Dublin, Ireland, to expand manufacturing
capacity and meet future growth targets.
Engineering firm AK Pharmaceuticals is to open a new Engineering
Centre of Excellence in Ireland, in a move that reaffirms the
healthy position of the Irish pharmaceutical industry. The move is
set to create 220 new jobs over the...
Ireland's pharmaceutical industry saw a return to strong growth in
July, after a lengthy period in which the prevailing wisdom was
that the sector had plateaued.
The Irish government is joining Johnson & Johnson subsidiary
Centocor in a €650 million investment in a new manufacturing
facility, it said this week. The move comes as some have questioned
the country's capacity to remain...
A science and technology advisory group has called on the Irish
government to ensure that the country remains competitive in the
pharmaceutical and chemical industries by developing R&D
operations and, in particular, fostering...
Ireland is developing a sound research base in the areas of
biotechnology and information and communication technologies (ICT),
despite institutional and funding barriers, concludes a recent
report by the national policy and advisory...
